BIO Overview

1. BIO Overview

2. BIO Fact Sheet • Founded: 1993 • Tax Status: Non-profit trade association • Pres & CEO: James C. Greenwood • Chairman: Steve Sherwin • Chairman & CEO • Cell Genesys • Headquarters: Washington, DC • Staff: 160 • Members: Approximately 1,200 organizations

3. BIO Mission • Create a positive environment that promotes continued biotech innovation • Policy • Legislative • Regulatory • Legal • BIO represents more than just an Industry • BIO represents Innovation • Business • Access to capital • Partnering • Public Opinion • Communications • Branding campaign

4. Membership Breakdown September 2009 Approximately 1,200 Members Revenue R&D Organizations: 67% Market Focus Industrial & Environmental: 8% ~800 R&D Members

7. Unique Trade Association • Diverse membership – “Big Tent” • Health, Food & Agriculture, Industrial & Environmental • Pre-emerging – Fortune 500 • International membership now greater than 20% • World-class advocacy team • Federal & state government relations • International initiative • Policy • Public relations • Coordinated lobbying effort • BIO • Member companies • State affiliates • Coalitions

8. Unique Trade Association • State affiliate network • 45 affiliates in 42 states • Coordinated state-level advocacy in all 42 states • Membership in BIO provides a voice in affiliate states • Coalition building • Patient groups • Academia • Other industry groups • Beyond traditional services • Business Solutions program for cost savings • Investor & Innovator conferences among best in the industry

9. 2009 Policy Issues • Biosimilars • Comparative Effectiveness • Reimbursement: patient access • Improving the performance of FDA • Intellectual property protection • International advocacy • Vaccine innovation & pandemic and bio-defense preparedness • Research tools & molecular diagnostics

10. Innovator & Investor Conferences Innovator: • BIO-Asia • BIO-Europe Spring • BIO-Windhover & • Windhover PSO • The Business Forum at the BIO International Convention • BIO-India • BIO-Europe Investor: • BIO CEO & Investor Conference • BIO National Venture Conference • BIO Investor Forum

11. Innovator Conference Elements • One-on-one partnering meetings • Scheduled via BIO’s proprietary online partnering system • Company presentations • Therapeutic and business expert panels • Networking receptions • Invitation-only events

12. Communications • Campaign Goals • Advance policy goals • Build, organize, and have the potential to mobilize a network of biotech advocates and brand ambassadors • Increase awareness & favorable opinion of biotechnology • Generate positive awareness among elites and those who influence opinion and policy

13. Cooperation with China • BIO China 2010 • Format • Two day event bringing together biotechnology and pharmaceutical companies from the US, Europe and Asia. • Company presentations, partnering (similar to the Business Forum at the BIO International Convention), and tracks on timely business development and policy topics.

14. Cooperation with China • BIO China 2010 • Attendees • Chinese biotech firms conducting R&D that seek to meet potential partners. • International pharmaceutical and biotech companies that seek to partner with Chinese based R&D companies or to out-license their technologies. • China based service providers. • Innovative biotech companies that seek partners or service providers.

15. Cooperation with China • Scientific American Worldview Scorecard • Launched at BIO 2009. • Analysis and ranking of biotech environment in countries across the globe. • Special look at regulatory, IP, education, infrastructure. • Focus on China in 2010. • Government Dialogues • U.S.-China Joint Commission on Commerce and Trade • BIO-SFDA Roundtables